Statistics

Total Visits

Views
Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial51

Select a period of time:

Number of views in the range

Views
Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial31

Views

Views
October 20240
November 20242
December 20242
January 20252
February 20255
March 202519
April 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore16
United States11
United Kingdom2
Austria1
Spain1
 

Top cities views

Views
Los Angeles1